← Leaderboards
David N Hayes
Univ Of North Carolina Chapel Hill
$17,915,459
Attributed
$39,413,702
Total exposure
8
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.5M · FY2009–25$10M$7.5M$5M$2.5M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$39,413,702 · 8
By mechanism
U24$24,632,871 · 3
R01$5,551,999 · 2
UG1$4,818,439 · 1
U10$3,410,394 · 1
RC1$999,999 · 1
Top collaborators
- Charles M Perou20 shared
- Katherine A. Hoadley10 shared
- Jason Derek Merker7 shared
- Paul Joseph Brennan6 shared
- Brenda B. Diergaarde6 shared
- Jose P. Zevallos5 shared
- Joel S Parker4 shared
- Scott M Hammond2 shared
Most similar at Univ Of North Carolina Chapel Hill
Same institution · by research overlap
- Katherine A. Hoadley$3,478,334
- Jen Jen Yeh$14,819,320
- Charles M Perou$46,508,459
- Xian Chen$10,292,209
- Joel S Parker$550,750
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsMutationTumorGenomicsSamplingThe Cancer Genome AtlasGene ExpressionTechnologyGenesBaseGenotypeTranscriptome SequencingCharacteristicsVariantCellsLaboratoriesProductionClinical TrialsClinically RelevantMalignant Breast NeoplasmCancer GenomeNext Generation SequencingDna SequenceDna Sequence Alteration
Grant awards (43)
UNITS: The UNC / UT National Clinical Trials Network Group Integrated Translational Science Production and Consultation Center$600,941
UG1 · FY2025 · CA
Specialized RNA analysis center for integrative genomic analyses$362,166
U24 · FY2025 · CA
UNITS: The UNC / UT National Clinical Trials Network Group Integrated Translational Science Production and Consultation Center$637,440
UG1 · FY2024 · CA
Specialized RNA analysis center for integrative genomic analyses$344,352
U24 · FY2024 · CA
UNITS: The UNC / UT National Clinical Trials Network Group Integrated Translational Science Production and Consultation Center$728,371
UG1 · FY2023 · CA
Specialized RNA analysis center for integrative genomic analyses$283,797
U24 · FY2023 · CA
UNITS: The UNC / UT National Clinical Trials Network Group Integrated Translational Science Production and Consultation Center$663,338
UG1 · FY2022 · CA
Specialized RNA analysis center for integrative genomic analyses$355,225
U24 · FY2022 · CA
UNITS: The UNC / UT National Clinical Trials Network Group Integrated Translational Science Production and Consultation Center$728,348
UG1 · FY2021 · CA
The role of germline and somatic DNA mutations in oral and oropharyngeal cancers$706,129
R01 · FY2021 · DE
Development of a Four-Class, Molecular Subtyping Diagnostic for HPV-negative Head and Neck Cancer$497,785
R01 · FY2021 · CA
Specialized RNA analysis center for integrative genomic analyses$376,349
U24 · FY2021 · CA
UNITS: The UNC / UT National Clinical Trials Network Group Integrated Translational Science Production and Consultation Center$730,001
UG1 · FY2020 · CA
The role of germline and somatic DNA mutations in oral and oropharyngeal cancers$613,147
R01 · FY2020 · DE
RNA sequencing analysis of Cancer$415,763
U24 · FY2020 · CA
Development of a Four-Class, Molecular Subtyping Diagnostic for HPV-negative Head and Neck Cancer$392,059
R01 · FY2020 · CA
The role of germline and somatic DNA mutations in oral and oropharyngeal cancers$46,718
R01 · FY2020 · DE
UNITS: The UNC / UT National Clinical Trials Network Group Integrated Translational Science Production and Consultation Center$730,000
UG1 · FY2019 · CA
The role of germline and somatic DNA mutations in oral and oropharyngeal cancers$631,228
R01 · FY2019 · DE
RNA sequencing analysis of Cancer$403,697
U24 · FY2019 · CA
Development of a Four-Class, Molecular Subtyping Diagnostic for HPV-negative Head and Neck Cancer$376,150
R01 · FY2019 · CA
The role of germline and somatic DNA mutations in oral and oropharyngeal cancers$630,189
R01 · FY2018 · DE
Network Group Integrated Translational Science Centers Application$610,519
U10 · FY2018 · CA
RNA sequencing analysis of Cancer$416,184
U24 · FY2018 · CA
Development of a Four-Class, Molecular Subtyping Diagnostic for HPV-negative Head and Neck Cancer$393,202
R01 · FY2018 · CA
Network Group Integrated Translational Science Centers Application$699,875
U10 · FY2017 · CA
The role of germline and somatic DNA mutations in oral and oropharyngeal cancers$650,254
R01 · FY2017 · DE
Development of a Four-Class, Molecular Subtyping Diagnostic for HPV-negative Head and Neck Cancer$615,138
R01 · FY2017 · CA
RNA sequencing analysis of Cancer$416,184
U24 · FY2017 · CA
Network Group Integrated Translational Science Centers Application$700,000
U10 · FY2016 · CA · contact PI
RNA sequencing analysis of Cancer$416,184
U24 · FY2016 · CA
Gene Expression Patterns in Human Tumors Identified Using Transcript Sequencing$151,313
U24 · FY2016 · CA
Network Group Integrated Translational Science Centers Application$700,000
U10 · FY2015 · CA · contact PI
Network Group Integrated Translational Science Centers Application$700,000
U10 · FY2014 · CA · contact PI
Gene Expression Patterns in Human Tumors Identified Using Transcript Sequencing$500,000
U24 · FY2014 · CA
Gene Expression Patterns in Human Tumors Identified Using Transcript Sequencing$3,777,133
U24 · FY2013 · CA
Gene Expression Patterns in Human Tumors Identified Using Transcript Sequencing$3,802,733
U24 · FY2012 · CA
Gene Expression Patterns in Human Tumors Identified Using Transcript Sequencing$3,916,513
U24 · FY2011 · CA
Gene Expression Patterns in Human Tumors Identified Using Transcript Sequencing$4,161,072
U24 · FY2010 · CA
Gene Expression Patterns in Human Tumors Identified Using Transcript Sequencing$834,674
U24 · FY2010 · CA
Micro RNA Regulation of Human Airway Epithelial Phenotype$499,999
RC1 · FY2010 · HL
Gene Expression Patterns in Human Tumors Identified Using Transcript Sequencing$3,699,532
U24 · FY2009 · CA
Micro RNA Regulation of Human Airway Epithelial Phenotype$500,000
RC1 · FY2009 · HL